email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2690-5787

LOJ Immunology  & Infectious Disease

Case Report Open Access

Inadvertent Sulfonylurea Overdose and Treatment with Octreotide: A Case Report

Volume 1 - Issue 1

Kamran Khan and Sameed Qureshi*

  • Author Information Open or Close
    • Department of medicine and allied, Northwest General Hospital and Research Centre, Peshawar, Pakistan

    *Corresponding author: Sameed Qureshi, Department of medicine and allied, Northwest General Hospital and Research Centre, Peshawar, Pakistan

Received: July 25, 2019;   Published: August 02, 2019

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Suicide attempts using hypoglycemic agents are uncommon but are associated with a high level of morbidity and mortality. A fifty-eight-year-old-gentleman with no history of diabetes was presented in a state of shock to the emergency room with the ingestion of 12 tablets of 2 mg glimepiride. The patient was in persistent state of hypoglycemia. In such cases of sulfonylurea toxicity, goal of therapy depends on the adequate glucose supplementation to maintain normal blood glucose level. Octreotide is an effective drug in preventing rebound hypoglycemia after sulfonylurea ingestion. Octreotide in combination with dextrose should be considered for first-line therapy in the treatment of sulfonylurea-induced hypoglycemia.

Keywords: Sulfonylurea; Overdose; Octreotide

Abstract| Introduction| Case Report| Discussion| References|

https://www.high-endrolex.com/21